A comprehensive strategy to discover inhibitors of the translesion synthesis DNA polymerase κ.
Human DNA polymerase kappa (pol κ) is a translesion synthesis (TLS) polymerase that catalyzes TLS past various minor groove lesions including N(2)-dG linked acrolein- and polycyclic aromatic hydrocarbon-derived adducts, as well as N(2)-dG DNA-DNA interstrand cross-links introduced by the chemotherap...
Main Authors: | Kinrin Yamanaka, Dorjbal Dorjsuren, Robert L Eoff, Martin Egli, David J Maloney, Ajit Jadhav, Anton Simeonov, R Stephen Lloyd |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3466269?pdf=render |
Similar Items
-
TRANSLESION DNA POLYMERASES AND CANCER
by: Nick eMakridakis, et al.
Published: (2012-09-01) -
Inhibition of mutagenic translesion synthesis: A possible strategy for improving chemotherapy?
by: Kinrin Yamanaka, et al.
Published: (2017-08-01) -
Inhibition of mutagenic translesion synthesis: A possible strategy for improving chemotherapy?
by: Yamanaka, Kinrin, et al.
Published: (2018) -
Diverse small molecule inhibitors of human apurinic/apyrimidinic endonuclease APE1 identified from a screen of a large public collection.
by: Dorjbal Dorjsuren, et al.
Published: (2012-01-01) -
Translesion Synthesis Polymerases in the Prevention and Promotion of Carcinogenesis
by: L. Jay Stallons, et al.
Published: (2010-01-01)